L. Achécar

Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis

Cardiac dysfunction in patients with cirrhosis

Cardiovascular predictors of death in patients with cirrhosis

A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation

The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going

Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis

Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine